**Major Developments**: Ganfeng Lithium (01772) plans to introduce strategic investor Wanxin Green Energy, acquiring a 44.2361% stake in Shenzhen Yichu for approximately RMB 664 million. Aneng Logistics (09956) has received a non-binding acquisition proposal from a consortium. Duality Bio-B (09606) intends to issue RMB shares for listing on the STAR Market of the Shanghai Stock Exchange. Fosun Pharma (02196): The Shenzhen Biomedicine Industry Fund plans to invest RMB 600 million to participate in Fosun Kerry's Series A financing. Shi Si Pharmaceutical Group (02005): Left Amlodipine Besylate tablets have received production registration approval. Kelun-Bio (06990): The core product of Bodo Trastuzumab for treating 2L+ HER2+ breast cancer has been approved for market launch by the National Medical Products Administration. Anhui Anqing (02696): The injectable HLX43 for thymic epithelial tumor treatment has been granted orphan drug designation by the U.S. Food and Drug Administration. CanSino Biologics-B (09966): The latest results of the Phase III clinical trial for KN026 will be presented as an LBA oral report at the 2025 ESMO conference. Youzhiyou Bio-B (02496): Interim data from the Phase II study of M701 for malignant pleural effusion will be released at the 2025 ESMO conference. Haixi New Drug (02637) has set a price limit, with its public offering in Hong Kong receiving 3165.1 times subscription. China National Nuclear Corporation (01763) has signed a memorandum of understanding for cooperation with the Brazilian National Nuclear Energy Commission to actively expand its international cooperation layout. Hong Kong Travel International (00308) has been granted a maximum of HKD 500 million non-committed revolving loan financing. Tianqi Lithium (09696): The Jiangsu Zhangjiagang project with an annual output of 30,000 tons of lithium hydroxide has successfully produced its first bag of battery-grade lithium hydroxide product. Weigao (01066): Weigao Blood Purification plans to issue exchangeable shares to acquire 100% of Weigao Purui. Zhonghuan New Energy (01735) has reached a strategic cooperation with Jilin Huajin to jointly promote green methanol and new energy projects. Jinjing New Energy (01783) plans to issue 50 million shares at a 1.31% premium, netting around HKD 154.9 million. **Share Repurchase/Changes in Holdings**: Xiaomi Group-W (01810) repurchased 10.7 million shares for HKD 494 million on October 17. Midea Group (00300) repurchased 3.0182 million A shares for HKD 220 million on October 17. **Operating Performance**: China Life (02628) has issued a positive profit warning, expecting net profit attributable to shareholders for the first three quarters to be between RMB 156.785 billion to RMB 177.689 billion, representing a year-on-year growth of about 50% to 70%. CH DISPLAY OPT (00334) reported total sales of 62.2 million units in the first three quarters, an increase of 84.3% year-on-year, with revenues rising by 83.8% to approximately RMB 5.407 billion. SF Holding (06936) reported a total revenue of RMB 27.007 billion from its express logistics, supply chain, and international businesses in September, an increase of 8.78% year-on-year. Lianyi Technology-W (09959) reported a total transaction volume processed by technological solutions of RMB 336.19 billion in the first three quarters, a year-on-year increase of 28.2%. Tsugami Machinery China (01651) issued a positive profit warning, expecting a mid-term profit attributable to shareholders of approximately RMB 502 million, an increase of about 48% year-on-year. Sinopec Engineering (02386) reported a total contract value signed in the first three quarters of RMB 91.347 billion, a year-on-year increase of 24.4%. Zijin Mining (02899) reported a net profit attributable to shareholders of RMB 37.864 billion in the first three quarters, a growth of 55.45% year-on-year. Zijin Gold International (02259) produced 32 tons of gold in the first nine months, with a net profit attributable to shareholders of USD 905 million. Chow Tai Fook (01929) reported a year-on-year increase of 4.1% in retail value for the second quarter. Xtep International (01368): The main brand Xtep achieved low single-digit year-on-year growth in retail sales in mainland China during the third quarter.